These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2472275

  • 1. Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens.
    Glimelius B, Hoffman K, Olafsdottir M, Påhlman L, Sjödén PO, Wennberg A.
    Eur J Cancer Clin Oncol; 1989 May; 25(5):829-35. PubMed ID: 2472275
    [Abstract] [Full Text] [Related]

  • 2. General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy. A longitudinal study.
    Glimelius B, Graf W, Hoffman K, Påhlman L, Sjödén PO, Wennberg A.
    Acta Oncol; 1992 May; 31(6):645-51. PubMed ID: 1281650
    [Abstract] [Full Text] [Related]

  • 3. Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.
    Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
    J Clin Oncol; 1989 Oct; 7(10):1437-46. PubMed ID: 2674332
    [Abstract] [Full Text] [Related]

  • 4. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
    Glimelius B.
    Ann Oncol; 1993 Mar; 4(3):235-40. PubMed ID: 8471555
    [Abstract] [Full Text] [Related]

  • 5. Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
    Abad A, Garcia P, Gravalos C, Tusquets I, Font A, Perez G, Cortés-Funes H, Fabregat X, Barnadas A, Rosell R.
    Cancer; 1995 Mar 15; 75(6):1238-44. PubMed ID: 7882275
    [Abstract] [Full Text] [Related]

  • 6. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
    Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK.
    J Clin Oncol; 1989 Oct 15; 7(10):1407-18. PubMed ID: 2476530
    [Abstract] [Full Text] [Related]

  • 7. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
    Glimelius B, Hoffman K, Graf W, Påhlman L, Sjödén PO.
    Cancer; 1994 Feb 01; 73(3):556-62. PubMed ID: 8299077
    [Abstract] [Full Text] [Related]

  • 8. Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.
    Jones DV, Winn RJ, Brown BW, Levy LB, Pugh RP, Wade JL, Gross HM, Pendergrass KB, Levin B, Abbruzzese JL.
    Cancer; 1995 Nov 15; 76(10):1709-14. PubMed ID: 8625038
    [Abstract] [Full Text] [Related]

  • 9. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
    Tokunaga Y, Kitaoka A, Yagi T, Tokuka A, Ohsumi K.
    Hepatogastroenterology; 2001 Nov 15; 48(37):128-32. PubMed ID: 11268947
    [Abstract] [Full Text] [Related]

  • 10. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.
    Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
    J Clin Oncol; 1992 Jun 15; 10(6):904-11. PubMed ID: 1588370
    [Abstract] [Full Text] [Related]

  • 11. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW.
    J Clin Oncol; 1989 Oct 15; 7(10):1427-36. PubMed ID: 2789272
    [Abstract] [Full Text] [Related]

  • 12. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
    Pronzato P, Vaira F, Vigani A, Losardo P, Bertelli G.
    Anticancer Res; 1995 Oct 15; 15(6B):2679-82. PubMed ID: 8669846
    [Abstract] [Full Text] [Related]

  • 13. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study.
    O'Connell MJ.
    Cancer; 1989 Mar 15; 63(6 Suppl):1026-30. PubMed ID: 2465076
    [Abstract] [Full Text] [Related]

  • 14. Palliative chemotherapy in metastatic colorectal carcinoma: comparison of two chemotherapeutic regimens.
    Bremnes RM, Wist EA.
    Anticancer Res; 1996 Mar 15; 16(2):921-6. PubMed ID: 8687152
    [Abstract] [Full Text] [Related]

  • 15. Postsurgical sequential methotrexate, fluorouracil, and leucovorin for advanced colorectal carcinoma: a preliminary study.
    Tokunaga Y, Hata K, Nishitai R, Kaganoi J, Nanbu H, Ohsumi K.
    J Surg Oncol; 1997 Sep 15; 66(1):45-50. PubMed ID: 9290692
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A.
    J Clin Oncol; 1996 Aug 15; 14(8):2274-9. PubMed ID: 8708717
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.
    Saltz LB, Douillard JY, Pirotta N, Alakl M, Gruia G, Awad L, Elfring GL, Locker PK, Miller LL.
    Oncologist; 2001 Aug 15; 6(1):81-91. PubMed ID: 11161231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.